Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Potential use of efalizumab in the treatment of T-cell-mediated diseases

Aug. 6, 2002

GRP promotes keratinocyte proliferation and wound healing in vitro and in vivo

Aug. 5, 2002

Access initiates OraDisc phase III trial, acquires rights to amlexanox

July 26, 2002

Karo Bio to outlicense KB-002611

July 25, 2002

Organogenesis negotiates return of Apligraf rights from Novartis

July 25, 2002

Celltech identifies new inhibitors of LFA-1/ICAM-1 interaction

July 17, 2002

New vitamin D analogues for skin disorders emerge from Roche R&D

July 17, 2002

BI-K0376 effective against multiresistant acne-associated bacteria

July 4, 2002

HuMax-IL-15 effective in mouse model of psoriasis

July 3, 2002

Researchers at Allergan identify inhibitors of P-450RAI

July 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...